Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 8.40 | 7.05 | 2.81 | 0.06 |
Depreciation/ Depletion | 0.25 | 0.16 | 0.17 | 0.12 |
Deferred Taxes | 0.36 | - | - | - |
Non- Cash Items | 0.30 | 0.01 | -0.42 | -0.30 |
Changesin Working Capital | -10.83 | -8.19 | -2.04 | -0.17 |
Cashfrom Operating Activities | -1.85 | -0.96 | 0.52 | -0.28 |
Capital Expenditures | -0.85 | 0.00 | -0.60 | -0.01 |
Other Investing Cash Flow Items Total | -3.69 | 0.12 | -0.25 | 0.04 |
Cashfrom Investing Activities | -4.54 | 0.11 | -0.85 | 0.03 |
Issuance( Retirement)of Stock Net | 10.91 | -0.20 | 0.00 | 0.48 |
Issuance( Retirement)of Debt Net | 0.09 | 0.48 | 0.06 | 0.00 |
Cashfrom Financing Activities | 11.01 | 0.28 | 0.06 | 0.48 |
Net Changein Cash | 4.61 | -0.57 | -0.27 | 0.23 |
Cash Taxes Paid | 1.57 | - | - | - |
Financing Cash Flow Items | - | - | 0.00 | 0.00 |
Shelter Pharma Dividend Shelter Pharma Bonus Shelter Pharma News Shelter Pharma AGM Shelter Pharma Rights Shelter Pharma Splits Shelter Pharma Board Meetings Shelter Pharma Key Metrics Shelter Pharma Shareholdings Shelter Pharma Profit Loss Shelter Pharma Balance Sheet Shelter Pharma Q1 Results Shelter Pharma Q2 Results Shelter Pharma Q3 Results Shelter Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks